Most importantly, over-expression of WW45 not only inhibited the tumorigenecity of lung cancer cells, but also impaired the de novo tumorigenesis of lung cancer driven by loss of LKB1 and mutated Kras (Kras G12D). This evidence concerns the gene STK11 and lung carcinoma.